Home Add to Favorite Contact Submit  
           23 September, 2017


    
Category:  Press » Science

 

NuView Life Sciences Liquid Biopsy Tech Changing the Cancer Diagnosis Industry

Popularity:
         Views: 439
2016-11-30 06:39:21     
Nuviewinfo.com

Park City, UT - November 28, 2016 -- Medical researchers have discovered and exploited genetic mutations that are expressed only in precancerous or malignant cells. However, in making a formal diagnosis of cancer, these genetic mutations can be especially hard to pinpoint within the body and, thus far, have not been used as a primary method of diagnosing cancer. Instead, different types of imaging tests—including X-rays, PET scans, mammography and ultrasound—have been used to identify cancerous masses. But while imaging scans can locate masses in the body, they cannot identify microscopic cancers or be used to classify the cellular composition of a tumor.1

Traditionally, tissue biopsies have been used as a method of gathering genetic material for analysis. They are very invasive to the patient, and some may refuse to have the procedure performed due to the pain and anxiety associated with sample collection. The analysis of each biopsy sample is also a labor-intensive process that involves the possibility of human error. In some cases, it simply isn’t feasible to obtain tissue samples from specific locations in the body, such as the brain. Furthermore, once a biopsy sample is taken, the delay until diagnostic results are available is often very long, with an average wait time of 27 days.1

Now, NuView Life Sciences (NVLS) is at the forefront of a developing technology sector within the medical industry. Liquid biopsies focus on identifying biomarkers from tumor cells that are present in body fluids, and this type of biopsy is becoming more important as medical care shifts to a precision medicine mindset. One report forecasts that the non-invasive cancer diagnostics market, which is primarily driven by liquid biopsy technology currently in use or in development, will grow by as much as 44% between 2015 and 2030. The early diagnosis of prostate, breast, colorectal and lung cancer is primarily what’s driving this market growth. These four types of cancer are expected to account for over 70% of the liquid biopsy market in 2030.2 By 2030, the global liquid biopsy market is expected to reach 5,958.3 million.3

NVLS is working to change the way cancer is diagnosed by developing its precision medicine NV-VPAC1 platform technology. NVLS’ chairman and CEO, Paul Crowe, explained, “We’re working towards using NV-VPAC1 in liquid biopsies, which is much less invasive, painful, and less costly overall compared to traditional surgical biopsy methods. Because cancer cells are identified by certain biomarkers that result from genetic mutations, NV-VPAC1 is being tested in in vitro diagnostic scenarios to confirm cancerous mutations in prostate cells contained in voided urine specimens.”

Liquid biopsies are more than just less invasive. These types of biopsies are able to gather more information about specific types of cancer and tumor cellular compositions than traditional biopsies, and there are fewer post-biopsy complications experienced by patients when using this new diagnostic method. There are also substantial cost savings to be had in using liquid biopsies, and these savings are shared not only by the patient, but also by third-party payers and the healthcare system as a whole.

Since NVLS is developing a liquid biopsy method using NV-VPAC1 technology, the company is already becoming a leader in non-invasive, precision medicine-based diagnostics.

“We believe that NV-VPAC1 could eventually be used to screen for cancer in other biological fluids, such as bloodserum, cerebral spinal fluid and saliva. After all, liquid biopsy technology has the potential to completely change the cancer diagnostics industry, and we want that change to be part of that change,” said Crowe.

About NuView Life Sciences:
Founded in 2005, NuView Life Sciences is a biotechnology company located in Park City, Utah, working to reform the way cancer is diagnosed and treated in today’s healthcare system. NuView is focused on creating precision cancer diagnostics and therapeutics to improve patient outcomes—while reducing healthcare costs—through the development and clinical application of its exclusive peptide analog technology, NV-VPAC1.

Led by a team of industry experts with decades of combined experience in healthcare and medical imaging technologies, NuView is poised to change how we look for and respond to cancer.

About Paul Crowe:
Paul Crowe is a veteran healthcare industry leader who has already helped develop several successful start-up and early-stage healthcare companies, bringing diagnostic ultrasound, nuclear magnetic resonance (NMR/MRI), mobile positron emission tomography (PET), and gamma knife radio surgery technology to domestic and international markets. He currently serves on the board of NuView Life Sciences, Radiosurgical Centers of San Diego, at Scripps Memorial Hospital.

URL: http://nuviewinfo.com/site/3/
Print press release      Bookmark this page
Related Press releases 
The Andean Sky God Website Has Expanded to Include the Voynich Manuscript (Popularity: ): July 18, 2013 – FORT LAUDERDALE, Florida – The Andean Sky God Website, originally created as an archeology site to demonstrate a strong connection between the Tiwanaku Empire and the Nazca Lines, has expanded in recent years to cover other historical mysteries. The latest investigation of Morten St. George, the site's founder, is now online and it concerns the world's most mysterious manuscript, a medieval document written in undecipherable code, ...
New Hallowell Shelving at A Plus Warehouse (Popularity: ): Indianapolis, Indiana - July 05, 2013 -- A Plus Warehouse is proud to announce a new item in the shelving line. The company is sure that this new item will easily become a customer favorite. This new item is the Deluxe Open and Closed Industrial Shelving.This item obviously falls under the industrial shelving line. Industrial shelving has always been an extremely powerful line at A Plus Warehouse. Industrial shelving is ...
GenScript launches a premier gene synthesis service “Gene-BrickTM” for building large DNA fragments (Popularity: ): PISCATAWAY, N. J., Jun 10, 2012 - GenScript USA Inc., an internationally recognized biology contract research organization (CRO) recently launched Gene-BrickTM, a premier gene synthesis service.The Gene-BrickTM premier gene synthesis service is specifically designed to meet demands of large DNA fragments which are used in synthetic biology research, such as the building of large genetic circuits and synthetic chromosomes.Gene-BrickTM services will synthesize ~10 Kb long DNA fragments as the fundamental ...
Remote Temperature Monitoring (Popularity: ): London - Following the introduction of the Corporate Homicide Bill and latterly the Health & Safety (Offences) Act, a much higher price has been placed on compliance and avoidance of negligence. This, combined with increasing pressures on both suppliers and customers to look at more environmentally sound practices, is set to revolutionise the future of Legionella management.The most cost effective method of compliance with current Legionella guidance is based around ...
Legal vs Home paternity test (Popularity: ): Home DNA Paternity Test In cases where a DNA test is required simply in order to satisfy one's own need to know, it is quicker, easier and cheaper to carry out a home DNA paternity test. This kind of test is carried out using oral swabs that are sent to you by the testing company at your home address or any other address of your choice. In cases where the alleged ...

Press release home snapshot 


Related Business 
SIRE Life Sciences (Popularity: ): SIRE Life Sciences is a Recruitment & Executive Search Consultancy dedicated exclusively to the European Life Science industry. SIRE Life Sciences provides a “Complete-Life-Science-Cycle-Search-Solution” to both Life Science Professionals and Life Science Employers operating in the European Life Science sector. We offer a tailor made European-wide service for both Permanent or Freelance solutions specialized in delivering into the world’s leading Life Science institutions.
University of Michigan Life Sciences Initiative (Popularity: ): Information on the Life Sciences Institute, the Life Sciences Corridor, the Life Sciences Values and Society program, and educational programs and events.
Life Sciences Consulting (Popularity: ): Tribiosys is a professional services company providing life sciences solutions to the bio pharmaceutical industry.
BioVision: World Life Sciences Forum (Popularity: ): Annual event dedicated to linking life sciences with news, society and industry. Contains newsletters and details about upcoming and previous conferences.
International Union Against Cancer (Popularity: ): Its objectives are to advance scientific and medical knowledge in research, diagnosis, treatment, and prevention of cancer, and to promote all other aspects of the campaign against cancer throughout the world.
University of Pittsburgh Cancer Institute (Popularity: ): Comprehensive cancer center located in Pennsylvania and offering cancer prevention, diagnosis and treatment. Provides access to support and community outreach services.
Anwel Life Sciences Pvt. Ltd. (Popularity: ): Anwel Life Sciences Pvt. Ltd. is one of the prominent manufacturer,supplier and exporter of chicory products,chicory based products and agro food products from Ankleshwar, Gujarat. We have complete understanding of the market situations and believe in upgrading ourselves according to the changing requirements of our clients.
Cambrex Life Sciences Corp. (Popularity: ): Offers analytical and cell culture products and contract services to the life sciences industry. Includes product, management, corporate, and investor information, for many countries, with headquarters in East Rutherford, New Jersey. (NYSE: CBM)
Faces of Lung Cancer (Popularity: ): To build public awareness of lung cancer, four national cancer organizations are uniting to launch a nationwide lung cancer awareness campaign. The goals of the campaign are to promote better diagnosis and treatment of the disease, increase research funding, and publicize medical advances and support services that can help reduce the deaths and suffering associated with lung cancer.
Board of Editors in the Life Sciences (BELS) (Popularity: ): Evaluates the proficiency of manuscript editors in the life sciences and to award credentials similar to those obtainable in other professions. Provides certifcations as Editor Life Sciences (ELS).